Related Experiment Video

Updated: Aug 19, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

MBD2 deficiency does not accelerate p53 mediated lymphomagenesis

Owen James Sansom1, Stefan Mark Bishop, Adrian Bird

  • 1Mammalian Genetics, Cardiff School of Biosciences, University of Cardiff, Museum Avenue, PO Box 911, Cardiff CF10 3US, UK.

Oncogene
|March 1, 2005
PubMed

Insights

Loss of methyl-binding domain protein 2 (Mbd2) does not accelerate lymphomagenesis in mice, unlike DNA methyltransferase 1 (DNMT1). This suggests Mbd2 is a safer therapeutic target for cancer than DNMT1.

Area of Science:

  • Epigenetics and Cancer Biology
  • Genomic Instability Research
  • Tumorigenesis Mechanisms

Background:

  • Recent studies link reduced DNA methylation via DNA methyltransferase 1 (DNMT1) to increased genomic instability and lymphomagenesis.
  • Previous research indicated that loss of methyl-binding domain protein 2 (Mbd2) suppresses intestinal tumorigenesis.

Purpose of the Study:

  • To investigate whether Mbd2 deficiency exacerbates lymphomagenesis.
  • To compare the effects of Mbd2 loss versus DNMT1 modulation on lymphomagenesis.
  • To evaluate Mbd2 as a potential therapeutic target in lymphomagenesis.

Main Methods:

  • Intercrossing Mbd2 deficient mice with p53 deficient and p53 heterozygous mice.
  • Assessing lymphomagenesis progression in the generated mouse models.
  • Comparing outcomes with known effects of DNMT1 modulation.

Main Results:

  • Loss of Mbd2 did not accelerate lymphomagenesis in the examined mouse models.
  • The impact of Mbd2 deficiency on lymphomagenesis differs significantly from that of DNMT1.

Conclusions:

  • Mbd2 deficiency does not promote lymphomagenesis.
  • MBD2 represents a potentially safer therapeutic target for preventing or treating lymphomagenesis compared to DNMT1.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...